Tsuchitani T, Kou W, Tomi M · CPT: pharmacometrics & systems pharmacology · 2026 · Article
Pharmacokinetic scenario comparison
13d5fbd0-b3f0-56eb-846a-f0eb643bca1dPrediction source Version of record · PDF page(s) 4, 7
Study 4ba38d4f-0a22-5201-8423-04201e49e386 · Prediction record (JSON)
Prediction fields
- Endpoint
- elimination_half_life · PDF page(s) 4, 7
- Family
- pharmacokinetic_exposure · PDF page(s) 4, 7
- Measured variable
- elimination_half_life · PDF page(s) 4, 7
- Metric
- fraction · PDF page(s) 4
- Model
- mechanistic_or_numerical · PDF page(s) 1, 4, 7
- Population
- simulated_system · PDF page(s) 1, 4, 7
- Unit
- hour · PDF page(s) 4, 7
psp470163-sup-0001-supinfo.txt · Publisher supplement · psp470163-sup-0001-supinfo.txt · Prediction-linked resource · PDF page 10 · Public availability reported by the authors · Primary file reviewed
Apixaban whole-body PBPK model source · Wiley supporting information · Data S1 (psp470163-sup-0001-supinfo.txt) · Prediction-linked resource · PDF page 3 · Availability reported by the authors · Curated resource record
Validation Related evidence · Unknown · Unknown · Not assessed · Partially comparable · Not applicable